Bayesian predictive approach to interim monitoring in clinical trials
Bayesian predictive approach to interim monitoring in clinical trials
复制标题
DOI:
10.1002/sim.2204
复制
发表时间:
2006-07-15
影响因子:
2
通讯作者:
Wang, MD
中科院分区:
文献类型:
--
作者:
Dmitrienko, A;Wang, MD
This paper reviews Bayesian strategies for monitoring clinical trial data. It focuses on a Bayesian stochastic curtailment method based on the predictive probability of observing a clinically significant outcome at the scheduled end of the study given the observed data. The proposed method is applied to derive efficacy and futility stopping rules in clinical trials with continuous, normally distributed and binary endpoints. The sensitivity of the resulting stopping rules to the choice of prior distributions is examined and guidelines for choosing a prior distribution of the treatment effect are discussed. The Bayesian predictive approach is compared to the frequentist (conditional power) and mixed Bayesian-frequentist (predictive power) approaches. The interim monitoring strategies discussed in the paper are illustrated using examples from a small proof-of-concept study-and a large mortality trial. Copyright (c) 2005 John Wiley & Sons, Ltd.